MicrosoftTeams-image (5).png
Lyophilized Injectable Market Primed to Surpass USD 5 Billion by 2031, According to Transparency Market Research
June 05, 2023 06:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 05, 2023 (GLOBE NEWSWIRE) -- The global lyophilized injectable market is projected to exceed value of US$ 5 Bn by 2031. It is expected to expand at a CAGR...
astrivax_high resolution.png
AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
May 30, 2023 00:00 ET | AstriVax
The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the company’s vaccine platform.  The non-dilutive financing builds upon the...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Monoclonal Antibodies Market Sales are Anticipated to reach US$ 588.0 Billion by 2032, Increasing at 11.8% CAGR: Market.us Report
May 26, 2023 01:50 ET | Market.Us
New York, May 26, 2023 (GLOBE NEWSWIRE) -- The Monoclonal Antibodies Market size was valued at USD 198.2 Bn in 2022. The total market revenue is expected to grow at a CAGR of 11.8%, reaching...
Valo Tx Logo.jpg
Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology
May 23, 2023 03:00 ET | Valo Therapeutics LTD
HELSINKI, Finland, May 23, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces that the first patient has been treated in...
Icosavax_Logo.jpg
Icosavax Announces $67.8 Million Registered Direct Offering of Common Stock
May 22, 2023 17:53 ET | Icosavax, Inc.
SEATTLE, May 22, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Icosavax_Logo.jpg
Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
May 22, 2023 17:37 ET | Icosavax, Inc.
–  IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in older adults – –  IVX-A12 was generally well tolerated with no vaccine-related SAEs – –  First demonstration of hMPV...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Vaccine Adjuvants Market Size and Value to Reach USD USD 3,933.7 Million by 2032 | Growing at CAGR of 13.6%
May 17, 2023 05:21 ET | Market.Us
New York, May 17, 2023 (GLOBE NEWSWIRE) -- The Vaccine Adjuvants Market size reached US$ 1,134.7 Million in 2022. Looking forward, Market.us expects the market to reach US$ 3,933.7 Million by 2032,...
MicrosoftTeams-image (5).png
Polymerase Chain Reaction (PCR) Market to Reach USD 8.1 Bn by 2028, rising at a 6.4% CAGR: TMR Report
May 04, 2023 15:00 ET | Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size stood at US$ 4.1 Bn in 2020 and is expected to surpass US$ 8.1 Bn by...
GMILogo_Vertical-Gradient.png
Pharmaceutical Drug Delivery Market to hit USD 3.2 Trillion by 2032, says Global Market Insights Inc.
May 03, 2023 08:10 ET | Global Market Insights Inc.
Selbyville, Delaware, May 03, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drug delivery market value is predicted to reach over USD 3.2 trillion by 2032, according to a new research report by...
Global Western Blotting Processors Market to Reach USD 1.94 Billion by 2030
April 25, 2023 19:00 ET | DataM Intelligence
Ohio, Cleveland, April 25, 2023 (GLOBE NEWSWIRE) -- Market Overview: Western blotting is a crucial process for the immunodetection of proteins, specifically proteins that are in low quantity. This...